Recently Updated Pages

Mechanism

Background

Ketamine

References 354 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 References Gonçalves...

Treatment-resistant depression – other reported treatments Depression and anxiety disorders CHAPT...

References 352 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 References Marcanton...

Management of treatment-resistant depression – other well- supported treatments Depression and an...

References Depression and anxiety disorders CHAPTER 3 References Dunner DL, et al. Prospective, ...

Management of treatment-resistant depression – commonly used treatments 348 The Maudsley® Prescri...

References 346 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 in treatment (British...

Notes Depression and anxiety disorders CHAPTER 3 Notes ■ ■Tools such as the Montgomery–Asberg Dep...

Drug treatment of depression 344 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 Dru...

References Depression and anxiety disorders CHAPTER 3 If COCPs are ineffective, not tolerated, or...

Clinical implications 474 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 3 Premenstru...

Subjective reports

What is the mechanism? Depression and anxiety disorders CHAPTER 3 References Schieveld JNM, et a...

References Depression and anxiety disorders CHAPTER 3 References Furukawa TA, et al. Meta-­analy...

Who is at risk?

How common are disinhibitory reactions with benzodiazepines? 472 The Maudsley® Prescribing Guidel...

Benzodiazepines and disinhibition